Pharmacoeconomic Analysis Of Anidulafungin, Micafungin, Caspofungin And Fluconazole In The Treatment Of Candidemia And/Or Invasive Candidiasis In Non-Neutropenic Adult Patients In Spain

To estimate the cost-effectiveness of three candins (anidulafungin, caspofungin, and micafungin) and generic fluconazole in the treatment of non-neutropenic adult patients with candidemia and/or invasive candidiasis (IC) in intensive care units (ICU) in Spain.

Source: Value in Health - October 23, 2015 Category: Global & Universal Authors: S Grau, J Pozo, E Romá, M Salavert, J Barrueta, C Peral, I Rodríguez, D Rubio-Rodríguez, C Rubio-Terrés Source Type: research